Quick Answer
Bionano Genomics, Inc. reported Earnings Per Share Diluted of $4.85 (loss) per share for the year ending 2025.
- Bionano Genomics, Inc. showed an increase of +94.5% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Bionano Genomics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $0.09 (loss) per share | Q3 2020: $0.08 (loss) per share | Q1 2021: $0.04 (loss) per share | Q2 2021: $0.07 (loss) per share | Q3 2021: $0.07 (loss) per share | Q1 2022: $0.11 (loss) per share | Q2 2022: $1.13 (loss) per share | Q3 2022: $1.10 (loss) per share | Q1 2023: $1.23 (loss) per share | Q2 2023: $1.24 (loss) per share | Q3 2023: $3.22 (loss) per share | Q1 2024: $35.75 (loss) per share | Q2 2024: $14.41 (loss) per share | Q3 2024: $30.92 (loss) per share | Q1 2025: $1.15 (loss) per share | Q2 2025: $1.99 (loss) per share | Q3 2025: $1.59 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), Bionano Genomics, Inc.'s Earnings Per Share Diluted has declined by 1,765.4%.
- Historical annual values: Fiscal year 2025: $4.85 (loss) per share | Fiscal year 2024: $88.13 (loss) per share | Fiscal year 2023: $408.60 (loss) per share | Fiscal year 2022: $4.58 (loss) per share | Fiscal year 2021: $0.26 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: